Tuberculosis screening and isoniazid preventive therapy implementation: a Brazilian experience. (Q51120505)

30 March 2018

title

Tuberculosis screening and isoniazid preventive therapy implementation: a Brazilian experience. (English)

1 reference

30 March 2018

1 reference

0 references

1

Soumya Swaminathan

1 reference

30 March 2018

Padmapriyadarsini Chandrasekaran

series ordinal

2

1 reference

30 March 2018

publication date

23 January 2014

1 reference

30 March 2018

Expert Review of Anti-infective Therapy

published in

1 reference

30 March 2018

volume

12

1 reference

30 March 2018

issue

3

1 reference

30 March 2018

page(s)

289-292

1 reference

30 March 2018

Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

Three months of rifapentine and isoniazid for latent tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

New regimens to prevent tuberculosis in adults with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

A recent HIV diagnosis is associated with non-completion of Isoniazid Preventive Therapy in an HIV-infected cohort in Cape Town

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

Isoniazid prevention of HIV-associated tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.880338

10.1586/14787210.2014.880338

21 January 2018

Identifiers

DOI

1 reference

30 March 2018

PubMed ID

24455973

1 reference

30 March 2018